AstraZeneca News — every source, one live feed
Track AstraZeneca news in real time — Anglo-Swedish pharmaceutical company with major oncology, cardiovascular, and rare disease franchises.. fllwup^ collects the latest AstraZeneca headlines from every major source into one live feed — free, no account, no algorithm. Coverage aggregated from BBC, Reuters, AP, NYT, TechCrunch, Al Jazeera, and 200+ other outlets.
Latest AstraZeneca headlines
- BioMarin bulks up bone unit with $275M Alesta buyout to challenge AstraZeneca — Fierce Biotech
- AstraZeneca Ends Phase 3 Lung Cancer Drug Trial After Review — WSJ
- AstraZeneca touts Enhertu, Orpathys dual lung cancer wins amid bispecific failure — Fierce Pharma
- AstraZeneca oncology veteran Alan Barge named CEO of 4C Biomed — The Pharma Letter
- AstraZeneca touts separate late-stage lung cancer wins with Tagrisso, Enhertu — Endpoints News
- AstraZeneca Vs. Bristol-Myers Squibb: Who’s The Better Bargain For Investors (NYSE:BMY) — Seeking Alpha
- Pharmalittle: We're reading about an AstraZeneca setback, falling U.S. drug prices, and more — STAT
- AstraZeneca pulls plug on late-stage lung cancer trial, taking another clinical blow — BioSpace
- AstraZeneca to discontinue eVOLVE-Lung02 Phase III trial — TipRanks
- AstraZeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports — CNBC
Follow AstraZeneca live on fllwup^ — or browse all topics.
More Global Stocks & ADRs: browse the category. Compare: fllwup^ vs Flipboard · vs Feedly · vs Google News · vs Apple News.